<html>
<head>PUBMED IDs for CSMD2</head>
<body bgcolor='#C5F0F2'><h1>CSMD2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12906867/'>Identification of two new members of the CSMD gene family.</a> August 9  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12943675/'>A novel giant gene CSMD3 encoding a protein with CUB and sushi multiple domains: a candidate gene for benign adult familial myoclonic epilepsy on human chromosome 8q23.3-q24.1.</a> August 29  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/20171287/'>Voxelwise genome-wide association study (vGWAS).</a> January 5  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21439553/'>The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.</a> October 25  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21723258/'>Identification of epigenetically silenced genes in human pancreatic cancer by a novel method &quot;microarray coupled with methyl-CpG targeted transcriptional activation&quot; (MeTA-array).</a> September 29  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24408017/'>Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.</a> June 25  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25189415/'>The mutational pattern of primary lymphoma of the central nervous system determined by whole-exome sequencing.</a> May 9  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25189397/'>Preface. Nitric oxide.</a> April 14  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25863124/'>Expression and clinical significance of genes frequently mutated in small cell lung cancers defined by whole exome/RNA sequencing.</a> August 25  2015<br></body></html>
